|
At Rook's, Emphasis Is on 'Etc.'; Veteran Retailer Stocks Something for Everyone, Finds a Niche in Music
|
Just across the District line you'll find Rook's Clothes & Etc., a
shop where 50-year-old owner William Rook has learned to stay one
step ahead of a very hip clientele.
In this part of Capitol Heights, that means knowing what's what in
the fickle world of urban contemporary fashion, scoping out potential
customers at late-night hip-hop shows, maintaining files of graffiti-
style designs by neighborhood artists.
Take one step into the store and it's obvious that the real secret
to the store's success is in its name. The key is the "et cetera."
"Everybody's got their own specialty," Rook said. ...
|
ARIUS Research and Protein Design Labs, Inc. Sign Agreement For Expanded Collaboration.
PR Newswire
; ARIUS Research Inc. (TSX-VE: YAR), a medical...antibodies for the potential treatment of cancer. ARIUS uses patented and proprietary processes to...kill cancer cells. Under the agreement, ARIUS will receive an upfront technology access...
|
|
|
ARIUS Research Signs Anti-Cancer Antibody Discovery Deal with Takeda.
PR Newswire
; ...April 3 /PRNewswire-FirstCall/ -- ARIUS Research Inc. (TSX-V: ARI) and Takeda...year, multi-product collaboration using ARIUS' FunctionFIRST(TM) Platform to discover...disease. Under the terms of the agreement, ARIUS will receive an upfront technology access...
|
|
|
Arius announces leading independent proxy firm, RiskMetrics ISS Canada, recommends shareholders vote for the arrangement involving its acquisition by Roche.
PR Newswire
; ...Sept. 9 /PRNewswire-FirstCall/ -- ARIUS Research Inc., (TSX: ARI), a biotechnology...transaction, and are recommending that ARIUS shareholders and warrant holders vote FOR...arrangement whereby Roche will acquire all of ARIUS' outstanding shares and warrants. "The...
|
|
|
ARIUS Research Signs Agreement with Protein Design Labs, Inc.
PR Newswire
; TSX Venture Exchange: YAR ARIUS Research Inc. (TSX-VE: YAR) today said that...two novel anti- cancer antibodies developed by ARIUS. During the collaborative research period, ARIUS will receive research funding. Should PDL exercise...
|
|
|
ARIUS announces manufacturing Agreement with Laureate Pharma For Trop-2 targeting antibody.
PR Newswire
; ...Jan. 31 /PRNewswire-FirstCall/ -- ARIUS Research Inc., (TSX: ARI), a biotechnology...company located in Princeton, New Jersey. ARIUS' Trop-2 antibody program targets a novel...milestones and move multiple candidates from the ARIUS pipeline of drug candidates forward...
|
|
|
Arius Features Preclinical Data on Antibody Candidates at Two Conferences.
PR Newswire
; ...Sept. 7 /PRNewswire-FirstCall/ -- ARIUS Research Inc., (TSX: ARI), a biotechnology...Symposium in San Francisco on September 7-8, Arius will report recent results of its antibody...the prevalence of the epitope targeted by Arius' antibody in breast cancer patients...
|
|
|
ARIUS announces manufacturing agreement with Avid Bioservices for CD44 Cancer Stem Cell antibody.
PR Newswire
; ...TORONTO, Dec. 5 /PRNewswire-FirstCall/ -- ARIUS Research Inc. (TSX: ARI), a biotechnology...supply of the drug for human clinical trials which ARIUS plans to initiate in 2008. ARIUS also announced it has scheduled a pre-IND meeting...
|
|
|
ARIUS announces allowance of US patent for lead anti-cancer antibody.
PR Newswire
; ...Aug. 1 /PRNewswire-FirstCall/ -- ARIUS Research Inc., (TSX: ARI), a biotechnology...antibody in the treatment of breast cancers. ARIUS now has 16 issued and allowed patents covering...2 antibody drug is in development by ARIUS for breast, prostate and liver cancers...
|
|
|
ARIUS to Present at BIO Emerging Company Investor Forum.
PR Newswire
; ...Functional Antibody TSX Venture Exchange: ARI ARIUS Research Inc. (TSX-V: ARI) has been...President and Chief Scientific Officer of ARIUS, will provide an overview of the company...Hotel. The presentation will focus on ARIUS' proprietary FunctionFIRST(TM) discovery...
|
|
|
ARIUS Announces Changes to Board of Directors.
PR Newswire
; ...Dec. 6 /PRNewswire-FirstCall/ -- ARIUS Research Inc., (TSX: ARI), a biotechnology...Rae will be a valuable addition to the ARIUS Board of Directors," said Dr. David...President and Chief Executive Officer of ARIUS. "Furthermore, his experience in strategic...
|
Find more facts and information related to the
article "At Rook's, Emphasis Is on 'Etc.'; Veteran ..."
